NEW

Three Heart Surgeons Discuss How to Beat Aortic Dissection’s Ticking Clock

Participating in this Q&A article are Bilal Shafi, MD, from Sutter Health in Santa Cruz, California; Wilson Szeto, MD, from Penn Presbyterian Medical Center in Philadelphia, Pennsylvania; and Grayson H. Wheatley III, MD, Wheatley Surgical in Nashville, Tennessee.

The Joint Commission, Joint Commission Resources Launch Data Transparency Initiative

The Joint Commission and Joint Commission Resources (JCR) Inc. have announced a new data transparency initiative – Data Analytics for Safe Healthcare (DASH).

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

Aerobiotix Inc., a manufacturer of air treatment devices for hospitals and health care, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system.

AAAHC Releases Updated Toolkit Outlining Ambulatory Procedure Considerations for Obese Patients

To help ASCs implement necessary precautions and prevent negative outcomes for obese patients, the Accreditation Association for Ambulatory Health Care (AAAHC) has published a fully revised Ambulatory Procedure Considerations for Obese Patients Toolkit.

Medtronic Announces Adaptix Interbody System

Medtronic plc has announced the U.S. launch of Adaptix Interbody System, the first navigated titanium implant with Titan nanoLOCK Surface Technology, a proprietary blend of surface textures on the macro, micro and nano levels.

The Adaptix Interbody System, mirrored after the veteran Capstone Spinal System, touts improved features for increased strength, subsidence resistance, easy insertion and data-backed bone growth, according to a news release.

The announcement was made during the virtual edition of the North American Spine Society (NASS) annual meeting. Adaptix received U.S. Food and Drug Administration (FDA) approval in August 2020.

This milestone represents the first 3D printed titanium implant, developed in house by Medtronic engineers, that incorporates the state-of-the-art Titan nanoLOCK Surface Technology.

Titan Spine, acquired in 2019, pioneered this surface technology that is the first to demonstrate the elements to be considered a nanotechnology for spinal devices as outlined in the FDA nanotechnology guidance document. Interbody implants are spacers that surgeons may insert between the vertebrae during spinal fusion surgery to help relieve pressure on nerves and hold the vertebrae in place while fusion occurs.

“Adaptix Interbody System allows me the best chance to meet my patients’ needs by confidently placing the implant under navigation and trusting the Titan nanoLOCK Surface Technology to allow the implant to promote fusion. Surface technology, material type, and implant design all play a role in bone growth process during fusion,” said J. Justin Seale, MD, of OrthoArkansas Spine Institute. “The unique features and world-class technologies make the Adaptix Interbody System a truly differentiated implant.”

The Adaptix Interbody System addresses surgeons’ universal needs of fusion outcomes and offers:

  • Trusted design with enhanced features.
  • Science-backed nano surface technology.
  • Navigation efficiency and confidence.

Medtronic continues to transform spine care and deliver on its Surgical Synergy strategy by offering solutions that integrate implants, biologics, and enabling technologies. Adaptix Interbody System is compatible with the Medtronic navigation platform (StealthStation Navigation and O-arm imaging) and the newly released Grafton DBF Inject, a unique graft delivery syringe that delivers an osteoinductive6 DBM into the surgical site.

“Adaptix Interbody System is an exciting addition to our portfolio that leads with our Titan nanoLOCK Surface Technology,” said Sharrolyn Josse, vice president and general manager of Medtronic Core Spine and Biologics division, which is part of the Restorative Therapies Group at Medtronic. “It is a fully navigated procedure, leveraging our leadership in navigation.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X